Monoclonal Antibodies

Aug 27, 2016 by in ONCOLOGY Comments Off on Monoclonal Antibodies

Monoclonal Antibodies Hossein Borghaei Matthew K. Robinson Gregory P. Adams Louis M. Weiner INTRODUCTION Antibody-based therapeutics are important components of the cancer therapeutic armamentarium. Early antibody therapy studies attempted to…

read more

Antiangiogenesis Agents

Aug 27, 2016 by in ONCOLOGY Comments Off on Antiangiogenesis Agents

Antiangiogenesis Agents Cindy H. Chau William Douglas Figg Sr. INTRODUCTION Blood vessels are indispensable for tumor growth and metastasis, and the formation of a new network of blood vessels from…

read more

Hormonal Agents

Aug 27, 2016 by in ONCOLOGY Comments Off on Hormonal Agents

Hormonal Agents Matthew P. Goetz Charles Erlichman Charles L. Loprinzi Manish Kohli INTRODUCTION Hormonal agents are commonly used as a treatment of hormonally responsive cancers, such as breast, prostate, or…

read more

Miscellaneous Chemotherapeutic Agents

Aug 27, 2016 by in ONCOLOGY Comments Off on Miscellaneous Chemotherapeutic Agents

Miscellaneous Chemotherapeutic Agents M. Sitki Copur Scott Nicholas Gettinger Sarah B. Goldberg Hari A. Deshpande HOMOHARRINGTONINE AND OMACETAXINE Homoharringtonine and its congener, harringtonine, are cephalotaxine esters isolated from the evergreen…

read more

Poly (ADP-ribose) Polymerase Inhibitors

Aug 27, 2016 by in ONCOLOGY Comments Off on Poly (ADP-ribose) Polymerase Inhibitors

Poly (ADP-ribose) Polymerase Inhibitors Alan Ashworth INTRODUCTION Cancer cells may harbor defects in DNA repair pathways leading to genomic instability. This can foster tumorigenesis but also provides a weakness that…

read more

Proteasome Inhibitors

Aug 27, 2016 by in ONCOLOGY Comments Off on Proteasome Inhibitors

Proteasome Inhibitors Christopher J. Kirk Brian B. Tuch Shirin Arastu-Kapur Lawrence H. Boise BIOCHEMISTRY OF THE UBIQUITIN-PROTEASOME PATHWAY The ubiquitin proteasome system is involved in the degradation of more than…

read more

Kinase Inhibitors as Anticancer Drugs

Aug 27, 2016 by in ONCOLOGY Comments Off on Kinase Inhibitors as Anticancer Drugs

Kinase Inhibitors as Anticancer Drugs Charles L. Sawyers INTRODUCTION In 2001, the first tyrosine-kinase inhibitor imatinib was approved for clinical use in chronic myeloid leukemia. The spectacular success of this…

read more

Antimicrotubule Agents

Aug 27, 2016 by in ONCOLOGY Comments Off on Antimicrotubule Agents

Antimicrotubule Agents Christopher J. Hoimes Lyndsay N. Harris MICROTUBULES Microtubules are vital and dynamic cytoskeletal polymers that play a critical role in cell division, signaling, vesicle transport, shape, and polarity,…

read more

Topoisomerase Interactive Agents

Aug 27, 2016 by in ONCOLOGY Comments Off on Topoisomerase Interactive Agents

Topoisomerase Interactive Agents Khanh T. Do Shivaani Kummar James H. Doroshow Yves Pommier CLASSIFICATION, BIOCHEMICAL, AND BIOLOGIC FUNCTIONS OF TOPOISOMERASES Nucleic acids (DNA and RNA) being long polymers, topoisomerases fulfill…

read more
Get Clinical Tree app for offline access